{"gao_id": "GAO-15-66", "published": "2014-10-24T12:00:00Z", "released": "2014-11-24T07:00:00Z", "summary": "", "title": "Medicare Program Integrity: CMS Pursues Many Practices to Address Prescription Drug Fraud, Waste, and Abuse", "topics": ["Monitoring", "Investigations by federal agencies", "Fraud", "Program abuses", "Fraud, waste, and abuse", "Substance abuse", "Internal controls", "Health care fraud", "Health Care", "Health care programs", "Agency evaluation", "Medicare", "Drug abuse prevention", "Prescription drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-15-66", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-15-66-highlights.pdf"}, {"title": "Full Report (39 pages)", "url": "https://www.gao.gov/assets/gao-15-66.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/670/667160.txt"}]}